A randomized, double blind, controlled, multi center study of Ilaparazole in the treatment of reflux esophagitis-Phase III clinical trial

Xue, Y; Qin, XH; Zhou, LY; Lin, SR; Wang, L; Hu, HT; Xia, JL

Zhou, LY (reprint author), Peking Univ, Hosp 3, Dept Gastroenterol, Beijing, Peoples R China.

CONTEMPORARY CLINICAL TRIALS, 2018; 68 (): 67

Abstract

Aim and background: Proton pump inhibitors (PPIs) are the main drugs for the treatment of reflux esophagitis. Phase II clinical trials showed that, co......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索